{
  "nctId": "NCT02059005",
  "briefTitle": "Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions",
  "officialTitle": "Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions",
  "protocolDocument": {
    "nctId": "NCT02059005",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2016-03-04",
    "uploadDate": "2017-10-11T14:53",
    "size": 421689,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02059005/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 97,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2014-11-18",
    "completionDate": "2017-02-28",
    "primaryCompletionDate": "2017-02-16",
    "firstSubmitDate": "2014-02-07",
    "firstPostDate": "2014-02-11"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* patient is 18 years or older\n* alcohol and/or drug screening score that indicates at least mild problem severity\n\nExclusion Criteria:\n\n* medical or psychiatric complications\n* patient was admitted to hospital directly from a drug and alcohol inpatient rehabilitation facility\n* patient reports plans to leave the area within the next 12 months\n* patient is unable to provide valid informed consent\n* patient is attending dialysis\n* patient is not English-speaking",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change in Substance Use Rates From Baseline",
        "description": "Urinalysis confirmed self-reported days of use for any substance, including alcohol, cocaine, marijuana, opiates, sedatives, and hallucinogens over time. Participants reported substance use for the 90 days prior to the assessment date.",
        "timeFrame": "0, 3, 6 months"
      }
    ],
    "secondary": [
      {
        "measure": "Change in Treatment Session Attendance From Baseline",
        "description": "Treatment sessions attended for alcohol or drug use issues over time. Participants self-reported attendance for the 6 months prior to the baseline assessment. During follow-up assessments, participants self-reported attendance since the last assessment date.",
        "timeFrame": "0, 3, 6, months"
      },
      {
        "measure": "Number of Hospitalizations and Use of Emergency Services",
        "description": "Days of hospitalization and days of use of acute emergency services after Baseline. Participants self-reported their service utilization for the 6 months prior to the baseline assessment. During follow-up assessments, participants self-reported their service utilization since the last assessment date.",
        "timeFrame": "0, 3, 6, months"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 34,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:27.887Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}